Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia

Giulio Giordano, Pier Francisco Ferrucci, Chiara Nicci, Tiziana Grafone, Rosa Tambaro, Stefano Papini, Giuliana Farina, Silvia Piano, Bruno Zappacosta, Sergio Storti

Research output: Contribution to journalArticle

Abstract

In neoplastic patients chemotherapy frequently involves severe myeloid suppression. Sometimes myeloid suppression is the main cause of therapy recycling delay with severe and prolonged neutropenia, anaemia and thrombocytopenia. Our study aimed to verify whether there is a correlation between reticulocyte fractions, reticulocyte indices, myeloperoxidase index (MPXI) and post-chemotherapy myelopoietic function and severe post-chemotherapy neutropenia. A cohort of 112 patients was identified, 30 with lymphoma or myeloma and 82 with solid neoplasms with bone marrow micrometastases. The patients were treated with chemotherapy (CT). After CT, 60 patients had neutropenia (ANC 10.7% a score of 1, and a score of 0 was assigned to the remaining patients. Patients with a score of 1 showed a lower number of neutropenic events (only 9 out of 36 patients) than those with a score of 0 (51 out of 76 patients), p

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalOncology Reports
Volume21
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Reticulocytes
Neutropenia
Peroxidase
Drug Therapy
Bone Marrow Neoplasms
Neoplasm Micrometastasis
Recycling
Thrombocytopenia
Anemia
Lymphoma

Keywords

  • Chemotherapy
  • Medium absorbance fraction of reticulocyte
  • Myeloperoxidase index
  • Neutropenia

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia. / Giordano, Giulio; Ferrucci, Pier Francisco; Nicci, Chiara; Grafone, Tiziana; Tambaro, Rosa; Papini, Stefano; Farina, Giuliana; Piano, Silvia; Zappacosta, Bruno; Storti, Sergio.

In: Oncology Reports, Vol. 21, No. 1, 2009, p. 193-198.

Research output: Contribution to journalArticle

Giordano, Giulio ; Ferrucci, Pier Francisco ; Nicci, Chiara ; Grafone, Tiziana ; Tambaro, Rosa ; Papini, Stefano ; Farina, Giuliana ; Piano, Silvia ; Zappacosta, Bruno ; Storti, Sergio. / Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia. In: Oncology Reports. 2009 ; Vol. 21, No. 1. pp. 193-198.
@article{9269d59c62dd434a9b60049d4458865e,
title = "Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia",
abstract = "In neoplastic patients chemotherapy frequently involves severe myeloid suppression. Sometimes myeloid suppression is the main cause of therapy recycling delay with severe and prolonged neutropenia, anaemia and thrombocytopenia. Our study aimed to verify whether there is a correlation between reticulocyte fractions, reticulocyte indices, myeloperoxidase index (MPXI) and post-chemotherapy myelopoietic function and severe post-chemotherapy neutropenia. A cohort of 112 patients was identified, 30 with lymphoma or myeloma and 82 with solid neoplasms with bone marrow micrometastases. The patients were treated with chemotherapy (CT). After CT, 60 patients had neutropenia (ANC 10.7{\%} a score of 1, and a score of 0 was assigned to the remaining patients. Patients with a score of 1 showed a lower number of neutropenic events (only 9 out of 36 patients) than those with a score of 0 (51 out of 76 patients), p",
keywords = "Chemotherapy, Medium absorbance fraction of reticulocyte, Myeloperoxidase index, Neutropenia",
author = "Giulio Giordano and Ferrucci, {Pier Francisco} and Chiara Nicci and Tiziana Grafone and Rosa Tambaro and Stefano Papini and Giuliana Farina and Silvia Piano and Bruno Zappacosta and Sergio Storti",
year = "2009",
doi = "10.3892/or_00000207",
language = "English",
volume = "21",
pages = "193--198",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia

AU - Giordano, Giulio

AU - Ferrucci, Pier Francisco

AU - Nicci, Chiara

AU - Grafone, Tiziana

AU - Tambaro, Rosa

AU - Papini, Stefano

AU - Farina, Giuliana

AU - Piano, Silvia

AU - Zappacosta, Bruno

AU - Storti, Sergio

PY - 2009

Y1 - 2009

N2 - In neoplastic patients chemotherapy frequently involves severe myeloid suppression. Sometimes myeloid suppression is the main cause of therapy recycling delay with severe and prolonged neutropenia, anaemia and thrombocytopenia. Our study aimed to verify whether there is a correlation between reticulocyte fractions, reticulocyte indices, myeloperoxidase index (MPXI) and post-chemotherapy myelopoietic function and severe post-chemotherapy neutropenia. A cohort of 112 patients was identified, 30 with lymphoma or myeloma and 82 with solid neoplasms with bone marrow micrometastases. The patients were treated with chemotherapy (CT). After CT, 60 patients had neutropenia (ANC 10.7% a score of 1, and a score of 0 was assigned to the remaining patients. Patients with a score of 1 showed a lower number of neutropenic events (only 9 out of 36 patients) than those with a score of 0 (51 out of 76 patients), p

AB - In neoplastic patients chemotherapy frequently involves severe myeloid suppression. Sometimes myeloid suppression is the main cause of therapy recycling delay with severe and prolonged neutropenia, anaemia and thrombocytopenia. Our study aimed to verify whether there is a correlation between reticulocyte fractions, reticulocyte indices, myeloperoxidase index (MPXI) and post-chemotherapy myelopoietic function and severe post-chemotherapy neutropenia. A cohort of 112 patients was identified, 30 with lymphoma or myeloma and 82 with solid neoplasms with bone marrow micrometastases. The patients were treated with chemotherapy (CT). After CT, 60 patients had neutropenia (ANC 10.7% a score of 1, and a score of 0 was assigned to the remaining patients. Patients with a score of 1 showed a lower number of neutropenic events (only 9 out of 36 patients) than those with a score of 0 (51 out of 76 patients), p

KW - Chemotherapy

KW - Medium absorbance fraction of reticulocyte

KW - Myeloperoxidase index

KW - Neutropenia

UR - http://www.scopus.com/inward/record.url?scp=61449285741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449285741&partnerID=8YFLogxK

U2 - 10.3892/or_00000207

DO - 10.3892/or_00000207

M3 - Article

C2 - 19082461

AN - SCOPUS:61449285741

VL - 21

SP - 193

EP - 198

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 1

ER -